Engineered recombinant ovomucoid third domain can modulate allergenic response in Balb/c mice model

Biochemical and Biophysical Research Communications

Volumn 342, Issue 3, 2006, Pages 710-717

  Rupa, Prithy ^a   Mine, Yoshinori ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Balb c mice; Food allergy; IgE; Immunotherapy; Ovomucoid; Site directed mutagenesis; Th1 Th2

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 12; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; RECOMBINANT DIII OVOMUCOID MUTANT ANTIGEN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; BIOENGINEERING; CHEMICAL ENGINEERING; CONTROLLED STUDY; EGG ALLERGY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE MUTATION; GENETIC VARIABILITY; IMMUNIZATION; IMMUNOSTIMULATION; IMMUNOTHERAPY; MOUSE; MOUSE STRAIN; MUTANT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; TH1 CELL; TH2 CELL;

ALLERGENS; ANIMALS; ANTIGENS; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HYPERSENSITIVITY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-4; MICE; MICE, INBRED BALB C; OVOMUCIN; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; SPLEEN; T-LYMPHOCYTES;

ANIMALIA; MURINAE;

EID: 33644631475     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.01.174     Document Type: Article

References (26)

1. D.B. Corry, and F. Kheradmand Induction and regulation of the IgE response Nature 402 1999 B18 B23
2. I. Kato, J. Schrode, W.J. Kohr, and M. Laskowski Chicken ovomucoid: determination of its amino acid sequence, determination of the trypsin reactive site and preparation of all three of its domains Biochemistry 26 1987 193 201
3. J.W. Zhang, and Y. Mine Characterization of IgE and IgG epitopes on ovomucoid using egg-white-allergic patients' sera Biochem. Biophys. Res. Commun. 253 1998 124 127
4. E. Sasaki, and Y. Mine IgE binding properties of the recombinant ovomucoid third domain expressed in Escherichia coli Biochem. Biophys. Res. Commun. 282 2001 947 951
5. Y. Mine, and J.W. Zhang Identification and fine mapping of IgG and IgE epitopes in ovomucoid Biochem. Biophys. Res. Commun. 292 2002 1070 1074
6. Y. Mine, and P. Rupa Genetic attachment of undecane peptides to ovomucoid third domain can suppress the production of specific IgG and IgE antibodies Biochem. Biophys. Res. Commun. 311 2003 223 228
7. H.L. Spiegelberg, L. Beck, H.P. Kocher, W.C. Fanslow, and A.H. Lucas Role of interleukin in human immunoglobulin E formation in hu-PBL-SCID mice J. Clin. Invest. 93 1994 711 717
8. C.M. Snapper, and W.E. Paul Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production Science 236 1987 944 947
9. J. Pene, F. Rousset, F. Briere, I. Chretien, J.Y. Bonnefoy, H. Spits, T. Yokota, N. Arai, K. Arai, J. Banchereau, and J.E. Vries IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2 Proc. Natl. Acad. Sci. USA 85 1988 6880 6884
10. F. Ferreira, C. Ebner, B. Kramer, G. Casari, P. Briza, A.J. Kungl, R. Grimm, B. Jahn- Schmid, H. Breiteneder, D. Kraft, M. Breitenbach, H.J. Rheinberger, and O. Scheiner Modulation of IgE reactivity of allergens by site-directed mutagenesis: potential use of hypoallergenic variants for immunotherapy FASEB J. 12 1998 231 242
11. C. Ebner, U. Siemann, B. Bohle, M. Willheim, U. Wiedermann, S. Schenk, F. Klotz, H. Ebner, D. Kraft, and O. Scheiner Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from Th2 to Th1 in T-cell clones specific for Ph1 p1, a major grass pollen allergen Clin. Exp. Allergy 27 1997 1007 1015
12. X.M. Li, K. Srivatsava, A. Grishin, C.K. Huang, B. Schofield, W. Burks, and H.A. Sampson Persistent protective effect of heat-killed Escherichia coli producing engineered recombinant peanut proteins in a murine model of peanut allergy J. Allergy Clin. Immunol. 112 2003 159 167
13. Y. Mine, E. Sasaki, and J.W. Zhang Reduction of antigenicity and allergenicity of genetically modified egg white allergen, ovomucoid third domain Biochem. Biophys. Res. Commun. 302 2003 133 137
14. U.K. Laemmli Cleavage of structural proteins during assembly of the head of bacteriophage T4 Nature 227 1970 680 685
15. P. Rupa, and Y. Mine Immunological comparison of native and recombinant egg allergen, ovalbumin, expressed in Escherichia coli Biotechnol. Lett. 25 2003 1917 1924
16. E. Maggi The TH1/TH2 paradigm in allergy Immunotechnology 3 1998 233 244
17. T.R. Mosmann, and R.L. Coffman TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties Ann. Rev. Immunol. 7 1989 145 173
18. M. Taniguchi, M. Harada, S. Kojo, T. Nakayama, and H. Wakao The regulatory role of Valpha14 NKT cells in innate and acquired immune response Ann. Rev. Immunol. 21 2003 483 513
19. T. Germann, and E. Rude Interleukin-12 Int. Arch. Allergy Immunol. 108 1995 103 112
20. G. Trinchieri Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes Blood 84 1994 4008 4027
21. A.B. Kay Allergy and allergic diseases. First of two parts N. Engl. J. Med. 344 2001 30 37
22. E. Raz, H. Tighe, Y. Sato, M. Corr, J.A. Dudler, M. Roman, S.L. Swain, H.L. Spiegelberg, and D.A. Carson Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization Proc. Natl. Acad. Sci. USA 93 1996 5141 5145
23. S. Vrtala, M. Focke-Tejkl, I. Swoboda, D. Kraft, and R. Valenta Strategies for converting allergens into hypoallergenic vaccine candidates Methods 32 2004 313 320
24. I. Swoboda, N. De Weerd, P.L. Bhalla, V. Niederberger, W.R. Sperr, P. Valent, H. Kahlert, H. Fiebig, P. Verdino, W. Keller, C. Ebner, S. Spitzauer, R. Valenta, and M.B. Singh Mutants of the major ryegrass pollen allergen, Lol p 5, with reduced IgE-binding capacity: candidates for grass pollen-specific immunotherapy Eur. J. Immunol. 32 2002 270 280
25. + T Cells by inhibiting serum-IgE-facilitated allergen presentation J. Immunol. 163 1999 2944 2952
26. H.J. Peng, S.N. Su, Z.N. Chang, P.L. Chao, S.W. Kuo, and L.C. Tsai Induction of specific Th1 response and suppression of IgE antibody by vaccination with plasmid DNA encoding Der f 11 Vaccine 20 2002 1761 1768